Advertisement

The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature

  • Paolo Delvino
  • Sara Monti
  • Silvia Balduzzi
  • Mirko Belliato
  • Carlomaurizio Montecucco
  • Roberto Caporali
Cases with a Message
  • 78 Downloads

Abstract

Diffuse alveolar haemorrhage (DAH) secondary to anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) is a rare life-threatening condition presenting with severe respiratory failure. The management of AAV-related DAH consists of remission induction immunosuppressive therapy, which requires time to be effective, with significant fatality rates despite appropriate treatment. Extracorporeal membrane oxygenation (ECMO) can support gas exchanges providing the time necessary for immunosuppressive treatment to control the underlying disease in cases refractory to the conventional ventilation techniques. Despite severe preexisting bleeding has been considered a relative contraindication, ECMO has proven to be life-saving in several cases of respiratory failure associated with pulmonary haemorrhage due to various causes, including AAV. We reviewed the clinical presentation and course of two patients affected by AAV-related DAH treated at our Institution between 2012 and 2017, whose management required the use of veno-venous ECMO. We reviewed the current literature on the role of ECMO in the support of these patients. In both patients, ECMO provided life support and allowed disease control, in combination with immunosuppressive treatment. Despite systemic anticoagulation, clinical improvement was achieved without exacerbation of the pulmonary bleeding. We performed a literature review, and summarized available data confirming the effectiveness and safety of ECMO in AAV-related DAH. ECMO has a life-saving role in the management of patients with severe respiratory failure due to ANCA-associated pulmonary capillaritis.

Keywords

ANCA-associated vasculitides Extra-corporeal membrane oxygenation Diffuse alveolar haemorrhage Respiratory failure 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare they have no conflict of interest.

References

  1. 1.
    Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ (1996) Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7(1):23–32PubMedGoogle Scholar
  2. 2.
    Haworth SJ, Savage CO, Carr D, Hughes JM, Rees AJ (1985) Pulmonary haemorrhage complicating Wegener’s granulomatosis and microscopic polyarteritis. BMJ (Clin Res Ed) 290(6484), 1775–1778Google Scholar
  3. 3.
    Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, Cordier JF (2000) Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d’Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM"O"P). Medicine 79(4):222–233CrossRefPubMedGoogle Scholar
  4. 4.
    Gallagher H, Kwan JTC, Jayne DRW (2002) Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 39(1):42–47CrossRefPubMedGoogle Scholar
  5. 5.
    Lewandowski K (2000) Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care 4(3):156–168CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Tulman DB, Stawicki SPA, Whitson BA, Gupta SC, Tripathi RS, Firstenberg MS et al (2014) Veno-venous ECMO: a synopsis of nine key potential challenges, considerations, and controversies. BMC Anesthesiol 14:65CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Cordell-Smith JA, Roberts N, Peek GJ, Firmin RK (2006) Traumatic lung injury treated by extracorporeal membrane oxygenation (ECMO). Injury 37(1):29–32CrossRefPubMedGoogle Scholar
  8. 8.
    Shin TG, Choi J-H, Jo IJ, Sim MS, Song HG, Jeong YK et al (2011) Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: a comparison with conventional cardiopulmonary resuscitation. Crit Care Med 39(1):1–7CrossRefPubMedGoogle Scholar
  9. 9.
    Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P et al (1997) Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM 90(6):401–409CrossRefPubMedGoogle Scholar
  10. 10.
    Rihová Z, Jancová E, Merta M, Zabka J, Rysavá R, Bartůnková J et al (2004) Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-associated vasculitis—preliminary single center experience. Prague Med Rep 105(1):64–68PubMedGoogle Scholar
  11. 11.
    Haubitz M, Bohnenstengel F, Brunkhorst R, Schwab M, Hofmann U, Busse D (2002) Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency. Kidney Int 61(4):1495–1501CrossRefPubMedGoogle Scholar
  12. 12.
    Krause ML, Cartin-Ceba R, Specks U, Peikert T (2012) Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin North Am 32(4):587–600CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Cordier J-F, Cottin V (2011) Alveolar hemorrhage in vasculitis: primary and secondary. Semin Respir Crit Care Med 32(3):310–321CrossRefPubMedGoogle Scholar
  14. 14.
    Hansell DM (2002) Small-vessel diseases of the lung: CT-pathologic correlates. Radiology 225(3):639–653CrossRefPubMedGoogle Scholar
  15. 15.
    De Lassence A, Fleury-Feith J, Escudier E, Beaune J, Bernaudin JF, Cordonnier C (1995) Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 151(1):157–163CrossRefPubMedGoogle Scholar
  16. 16.
    Janssen NM, Karnad DR, Guntupalli KK (2002) Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin 18(4):729–748CrossRefPubMedGoogle Scholar
  17. 17.
    Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya J-M (2013) Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev 12(3):380–395CrossRefPubMedGoogle Scholar
  18. 18.
    Monti S, Montecucco C, Pieropan S, Mojoli F, Braschi A, Caporali R (2015) Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series. Clin Exp Rheumatol 33(2 Suppl 89):S–S126PubMedGoogle Scholar
  19. 19.
    Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T et al (2016) EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75(9):1583–1594CrossRefPubMedGoogle Scholar
  20. 20.
    Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698):1351–1363CrossRefPubMedGoogle Scholar
  21. 21.
    Knoch M, Köllen B, Dietrich G, Müller E, Mottaghy K, Lennartz H (1992) Progress in veno-venous long-term bypass techniques for the treatment of ARDS. Controlled clinical trial with the heparin-coated bypass circuit. Int J Artif Organs 15(2):103–108CrossRefPubMedGoogle Scholar
  22. 22.
    Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C et al (2018) Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 378(21):1965–1975CrossRefPubMedGoogle Scholar
  23. 23.
    Hartmann A, Nordal KP, Svennevig J, Noddeland H, Pedersen T, Skarbøvik AJ et al (1994) Successful use of artificial lung (ECMO) and kidney in the treatment of a 20-year-old female with Wegener’s syndrome. Nephrol Dial Transplant 9(3):316–319PubMedGoogle Scholar
  24. 24.
    Loscar M, Hummel T, Haller M, Briegel J, Wiebecke B, Samtleben W et al (1997) ARDS and Wegener granulomatosis. Der Anaesthesist 46(11):969–973CrossRefPubMedGoogle Scholar
  25. 25.
    Matsumoto T, Ueki K, Tamura S, Ideura H, Tsukada Y, Maezawa A et al (2000) Extracorporeal membrane oxygenation for the management of respiratory failure due to ANCA-associated vasculitis. Scand J Rheumatol 29(3):195–197CrossRefPubMedGoogle Scholar
  26. 26.
    Mikami M, Mori Y, Yamazaki A, Konta A, Saito D, Owada S (2000) Efficacy of the extra-corporeal lung assist (ECLA) on the alveolar hemorrhage in a case with microscopic polyarteritis nodosa. Nihon Naika Gakkai Zasshi J Jpn Soc Internal Med 89(8):1651–1653CrossRefGoogle Scholar
  27. 27.
    Hernandez MEC, Lovrekovic G, Schears G, Helfaer M, Friedman D, Stafford P et al (2002) Acute onset of Wegener’s granulomatosis and diffuse alveolar hemorrhage treated successfully by extracorporeal membrane oxygenation. Pediatr Crit Care Med 3(1):63–66CrossRefPubMedGoogle Scholar
  28. 28.
    Rosengarten A, Elmore P, Epstein J (2002) Long distance road transport of a patient with Wegener’s granulomatosis and respiratory failure using extracorporeal membrane oxygenation. Emerg Med (Fremantle) 14(2):181–187CrossRefGoogle Scholar
  29. 29.
    Ahmed SH, Aziz T, Cochran J, Highland K (2004) Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage. Chest 126(1):305–309CrossRefPubMedGoogle Scholar
  30. 30.
    Agarwal HS, Taylor MB, Grzeszczak MJ, Lovvorn HN, Hunley TE, Jabs K et al (2005) Extra corporeal membrane oxygenation and plasmapheresis for pulmonary hemorrhage in microscopic polyangiitis. Pediatr Nephrol 20(4):526–528CrossRefPubMedGoogle Scholar
  31. 31.
    Balasubramanian SK, Tiruvoipati R, Chatterjee S, Sosnowski A, Firmin RK (2005) Extracorporeal membrane oxygenation with lepirudin anticoagulation for Wegener’s granulomatosis with heparin-induced thrombocytopenia. ASAIO J 51(4):477–479CrossRefPubMedGoogle Scholar
  32. 32.
    Di Maria MV, Hollister R, Kaufman J (2008) Case report: severe microscopic polyangiitis successfully treated with extracorporeal membrane oxygenation and immunosuppression in a pediatric patient. Curr Opin Pediatr 20(6):740–742CrossRefPubMedGoogle Scholar
  33. 33.
    Zhong H, Chen J, Li S, Jiang L, Li X, Han B (2008) Extracorporeal membrane oxygenation for pulmonary hemorrhage in microscopic polyangiitis. Chin Med J 121(24):2622–2623PubMedGoogle Scholar
  34. 34.
    Guo Z, Li X, Jiang L-Y, Xu L-F (2009) Extracorporeal membrane oxygenation for the management of respiratory failure caused by diffuse alveolar hemorrhage. J Extra Corpor Technol 41(1):37–40PubMedPubMedCentralGoogle Scholar
  35. 35.
    Paden ML, Warshaw BL, Heard ML, Fortenberry JD (2011) Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation. Pediatr Crit Care Med 12(2):153–158CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Joseph M, Charles AG (2011) Early extracorporeal life support as rescue for Wegener granulomatosis with diffuse alveolar hemorrhage and acute respiratory distress syndrome: a case report and literature review. Pediatr Emerg Care 27(12):1163–1166CrossRefPubMedGoogle Scholar
  37. 37.
    Barnes SL, Naughton M, Douglass J, Murphy D (2012) Extracorporeal membrane oxygenation with plasma exchange in a patient with alveolar haemorrhage secondary to Wegener’s granulomatosis. Internal Med J 42(3):341–342CrossRefGoogle Scholar
  38. 38.
    Keller R, Torres S, Iölster T, Kreutzer C, Fraire R, Grassi M et al (2012) Extracorporeal membrane oxygenation and plasmapheresis in the treatment of severe pulmonary hemorrhage secondary to nodose polyarteritis. Arch Argent Pediatr 110(4):e80–e85CrossRefPubMedGoogle Scholar
  39. 39.
    Hohenforst-Schmidt W, Petermann A, Visouli A, Zarogoulidis P, Darwiche K, Kougioumtzi I et al (2013) Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis. Drug Des Devel Ther 7:627–633PubMedPubMedCentralGoogle Scholar
  40. 40.
    Yusuff H, Malagon I, Robson K, Parmar J, Hamilton P, Falter F (2015) Extracorporeal membrane oxygenation for Life-threatening ANCA-positive pulmonary capillaritis. A review of UK experience. Heart Lung Vessel 7(2):159–167PubMedPubMedCentralGoogle Scholar
  41. 41.
    Rawal G, Kumar R, Yadav S (2016) ECMO rescue therapy in diffuse alveolar haemorrhage: a case report with review of literature. J Clin Diagn Res 10(6):OD10–O11PubMedPubMedCentralGoogle Scholar
  42. 42.
    Vanoli J, Riva M, Vergnano B, D’Andrea G, L’Imperio V, Pozzi MR et al (2017) Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: a case report. Medicine, 96(13), e6024Google Scholar
  43. 43.
    Kelly D, Makkuni D, Ail D (2017) Rare cause of respiratory failure in a young woman: isolated diffuse alveolar haemorrhage requiring extracorporeal membrane oxygenation. BMJ Case Rep.  https://doi.org/10.1136/bcr-2017-219235 CrossRefPubMedGoogle Scholar
  44. 44.
    Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A et al (1990) Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener’s granulomatosis. Arthritis Rheum 37(6):919–924CrossRefGoogle Scholar
  45. 45.
    Myers JL (1993) Diagnosis of drug reactions in the lung. Monogr Pathol 36:32–53Google Scholar
  46. 46.
    Malik SW, Myers JL, DeRemee RA, Specks U (1996) Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 154(6 Pt 1):1851–1856CrossRefPubMedGoogle Scholar
  47. 47.
    Uziel L, Cugno M, Fabrizi I, Pesenti A, Gattinoni L, Agostoni A (1990) Physiopathology and management of coagulation during long-term extracorporeal respiratory assistance. Int J Artif Organs 13(5):280–287CrossRefPubMedGoogle Scholar
  48. 48.
    Brunet F, Belghith M, Mira JP, Lanore JJ, Vaxelaire JF, Dall’ava Santucci J et al (1993) Extracorporeal carbon dioxide removal and low-frequency positive-pressure ventilation. Improvement in arterial oxygenation with reduction of risk of pulmonary barotrauma in patients with adult respiratory distress syndrome. Chest 104(3):889–898CrossRefPubMedGoogle Scholar
  49. 49.
    McCoy-Pardington D, Judd WJ, Knafl P, Abruzzo LV, Coombes KR, Butch SH et al (1990) Blood use during extracorporeal membrane oxygenation. Transfusion 30(4):307–309CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Rheumatology Department, IRCCS Policlinico S. Matteo FoundationUniversity of PaviaPaviaItaly
  2. 2.University of PaviaPaviaItaly
  3. 3.UOS Advanced Respiratory Intensive Care Unit, UOC Anestesia e Rianimazione 1IRCCS Policlinico S. Matteo FoundationPaviaItaly

Personalised recommendations